Navigation Links
Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth

Operating Income Exceeds $1 Million; Recurring Revenues Climb 84%; Free Cash Flow Exceeds $1.7 Million

DENVER, May 15 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, today reported profitability and its tenth consecutive quarter of revenue growth for the first quarter ended March 31, 2009.


Global Med's record revenues of $8.359 million for the first quarter of 2009 represent an increase of $3.766 million or 82% over the $4.593 million recorded for the comparable 2008 period. In the first quarter of 2009, operating income improved to $1.057 million from $625 thousand during the comparable 2008 period. The Company's net income for the first quarter of 2009 was $321 thousand, or $0.01 per basic common share outstanding, versus $360 thousand, or $0.01 per basic common share outstanding, for the comparable 2008 period.

Global Med's cash flow from operations for the first quarter of 2009 was $1.750 million, up 102% over the $867 thousand recorded for the comparable 2008 period.

Recurring annual maintenance revenues for the quarter were running at an annualized rate of over $16.3 million. Based on the backlog as of March 31, 2009, the Company's annual recurring revenues, when all contracted customer sites are implemented, will be approximately $17.2 million, an increase of 84% over 2008. The Company's backlog of unrecognized software license fees and implementation fees was approximately $8.9 million, an increase of 55% over 2008.

First Quarter 2009 Business Developments and Announcements:

  • With the licensing of the Company's SafeTrace Tx(R) transfusion management system to Brattleboro Memorial Hospital in Vermont, Global Med's medical information systems are now in all 50 States.
  • The Company licensed ElDorado(TM) software solutions to MedStar Health of Baltimore, MD, a $3.5 billion, 8-hospital organization in the mid-Atlantic region.
  • The Company licensed its leading European blood and laboratory solutions to Homburg, Germany healthcare facility - the University of Saarland Clinic Blood Center chose Inlog's EdgeBlood and EdgeLab to manage its blood bank and laboratory.
  • Global Med licensed its 90th site in the Southeastern U.S. to Laurens County Health System of Clinton, South Carolina to automate its blood bank with Global Med's SafeTrace Tx(R) transfusion management system.
  • Global Med's subsidiary, Inlog, placed its EdgeLab laboratory information system at the Fontainebleau Hospital to replace their out-dated Legacy LIS.
  • The Company licensed eDonor(R), ElDorado Donor(TM), and Donor Doc(TM) integrated donor management systems to South Texas Blood & Tissue Center of San Antonio, Texas, one of the top ten donor centers in the United States.
  • During the quarter, the Company announced that its Inlog subsidiary had licensed EdgeTrack to 62 French hospitals in 2008, including 19 Hospitals in Q4 2008 alone, confirming its leading position in the French hospital market with more than 130 installations.
  • Global Med licensed its SafeTrace Tx(R) transfusion management software to Good Samaritan Hospital of Vincennes, Indiana. The hospital also contracted with PeopleMed(TM), Inc., a subsidiary of Global Med, to validate their software.

Michael I. Ruxin, M.D., Chairman and CEO of Global Med Technologies, Inc., commenting on the first quarterly results, stated, "The Company continues to perform well in spite of a difficult economic climate. We experienced record revenues and operating profits in the first quarter with double digit increases in revenues, operating income, and cash flow from operations. It is important to note that operating income nearly doubled and cash flow from operations saw an impressive 102% increase." Dr. Ruxin continued, "Our recent acquisitions and strategic entry into the European market are showing early success and our integration efforts continue on track. We are also pleased to report that our domestic operations are continuing to experience strong growth in revenues and increased profits."

Thomas F. Marcinek, the Company's President and COO, stated, "Global Med continues to execute on its business plan. At this time, our sales bookings are on track to meet our annual goals. Operationally we are delivering products and services to drive our revenue. Finally and most important, our planned cost reductions are enhancing profitability without impacting our ability to deliver revenue."

The following table provides information related to the Company's operations for the three months ended March 31, 2009 and 2008:

                            Selected Results
                       Three Months Ended March 31,
                   In (000s) Except Per Share Information

                                        2009             2008
                                        ----             ----
        Revenues                      $8,359           $4,593
        Cost of revenues               3,040            1,558
        Operating expenses             4,262            2,410
        Income from operations         1,057              625
        Other income, (expenses)
         and (taxes)                    (736)            (265)
        Net income                      $321             $360
        Income per share
          Basic                        $0.01            $0.01
          Diluted                      $0.01            $0.01

        Weighted average shares
          Basic                       34,088           26,935
          Diluted                     43,452           44,915
        Cash flows provided by
         operations                   $1,750             $867

                            Selected Balance Sheet Data
                                   In (000s)

                                               March 31,     December 31,
                                                 2009            2008
                                                 ----            ----
    Cash, cash equivalents, and
     marketable securities                      $5,936          $4,660
    Other current assets                         9,549           9,566
    Current assets                              15,485          14,226
    PP&E                                         1,345           1,385
    Intangible assets                           13,519          14,081
    Other long-term assets                         136              92
    Total assets                               $30,485         $29,784
                                                ======          ======
    Accounts payable, accrued expenses,
     and other current liabilities              $7,018          $6,759
    Deferred revenue                             6,995           6,361
    Current portion, long-term debt              2,339           2,335
    Total current liabilities                   16,352          15,455
    Long-term debt                               7,534           7,853
    Other long-term liabilities                  1,065           1,065
    Total liabilities                           24,951          24,373

    Total stockholders' equity                   5,534           5,411
    Total liabilities and stockholders'
     equity                                    $30,485         $29,784
                                               =======          ======

The Company will host a conference call at 11:00 a.m. Eastern today. Callers within the U.S. should call: 1-866-394-9731. Callers that are outside of the U.S. should call: 1-706-643-7541. Callers should reference "Global Med First Quarter Financial Results" to the conference call operator. The conference call ID number will be: 98847282.

About Global Med Technologies(R), Inc.

Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.

Global Med's domestic companies are Wyndgate Technologies(R), a leader in software products and services for donor centers and hospital transfusion services; eDonor(R), which offers web-based donor relationship management systems; and PeopleMed(TM), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.

For more information about Global Med's products and services, please call 800-996-3428 or visit

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

SOURCE Global Med Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Global Warming Biggest Health Threat of 21st Century, Experts Say
2. IBM Establishes Global Healthcare Centre of Excellence in La Gaude, France
3. GAA Calls For a Worldwide Response to President Obamas Global Health Budget Shortfalls
4. Misonix Announces Participation in Annual Diabetic Foot Global Conference
5. CSC Receives SAP Pinnacle Award for Global IT Outsourcing
6. Aflac Tops the Global Insurance Industry for Reputation
7. Bausch & Lomb Appoints Global Vision Care and North American Vision Care Presidents
8. iMedica Appoints Dr. Ray Fabius, Global Physician Executive, to Board of Directors
9. A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier
10. Budget: Obama Retreats on Global AIDS, Says AHF
11. Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession
Post Your Comments:
(Date:1/17/2017)... ... 17, 2017 , ... Peoples Health is pleased to announce ... Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more than ... to our provider network, and the addition will benefit our members in the ...
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, pocket knife, luggage and ... to Cradle Product Design Challenge , the Cradle to Cradle Products Innovation Institute ... design challenges scheduled to run through early 2018. The challenges are presented by the ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Neil H. ... financial planning assistance to communities throughout the region, is launching a charity drive to ... disease is by far the deadliest killer in America, and is responsible for 1 ...
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading ... a Principal in its IT Advisory Services practice . Rossi is the third ... market demand for strategic IT guidance grows, and the practice continues to expand.     , ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... and eliminate cyber threats in real-time, today announced a strategic partnership with ... Selangor, Malaysia. Joining other Seceon partners, TechLab Security has become a strategic partner ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- Edwards Lifesciences Corporation (NYSE: EW ), the ... and critical care monitoring, plans to announce its operating ... the market closes on Wednesday, February 1, 2017, and ... that day to discuss those results. To ... (201) 689-8037.  For 72 hours following the call, an ...
(Date:1/17/2017)... PUNE, India , Jan. 17, 2017  Market Research Future ... Global Endoscopy Devices Market is expected to reach USD 33.6 million ... 2016. Market Highlights ... The Global Endoscopy Devices Market has been examined as ... rate. Globally there is huge demand for endoscopy device in various ...
(Date:1/17/2017)... Research and Markets has announced the addition of the ... offering. ... global fluoropolymer market in the healthcare industry to grow at a ... Fluoropolymer Market in the Healthcare Industry 2016-2020, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology: